Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells

Title: Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
Authors: Seguin, Laetitia; Odouard, Soline; Corlazzoli, Francesca; Al Haddad, Sarah; Moindrot, Laurine; Calvo Tardon, Marta; Yebra, Mayra; Koval, Alexey; Marinari, Eliana; Bes, Viviane; Guerin, Alexandre; Allard, Mathilde Camille; Ilmjarv, Sten; Katanaev, Vladimir; Walker, Paul Richard; Krause, Karl-Heinz; Dutoit Vallotton, Valérie; Sarkaria, Jann N.; Dietrich, Pierre-Yves; Cosset, Erika
Source: ISSN: 2399-3642 ; Communications Biology, vol. 4, no. 1 (2021) 718.
Publication Year: 2021
Collection: Université de Genève: Archive ouverte UNIGE
Subject Terms: info:eu-repo/classification/ddc/612; info:eu-repo/classification/ddc/616; info:eu-repo/classification/ddc/616.07
Description: Recently, we involved the carbohydrate-binding protein Galectin-3 (Gal-3) as a druggable target for KRAS-mutant-addicted lung and pancreatic cancers. Here, using glioblastoma patient-derived stem cells (GSCs), we identify and characterize a subset of Gal-3high glioblastoma (GBM) tumors mainly within the mesenchymal subtype that are addicted to Gal-3-mediated macropinocytosis. Using both genetic and pharmacologic inhibition of Gal-3, we showed a significant decrease of GSC macropinocytosis activity, cell survival and invasion, in vitro and in vivo. Mechanistically, we demonstrate that Gal-3 binds to RAB10, a member of the RAS superfamily of small GTPases, and β1 integrin, which are both required for macropinocytosis activity and cell survival. Finally, by defining a Gal-3/macropinocytosis molecular signature, we could predict sensitivity to this dependency pathway and provide proof-of-principle for innovative therapeutic strategies to exploit this Achilles' heel for a significant and unique subset of GBM patients.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/34112916; info:eu-repo/semantics/dataset/url/https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/geo/query/acc.cgi?acc=GSE173784; unige:152352
Availability: https://archive-ouverte.unige.ch/unige:152352
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.39F64952
Database: BASE